Stockscreener 앱 받기
4.55
2.05%
-0.095
전일 마감가:
$4.645
열려 있는:
$4.64
하루 거래량:
30,558
Relative Volume:
0.02
시가총액:
$7.27M
수익:
$6.59M
순이익/손실:
$-18.12M
주가수익비율:
-0.4809
EPS:
-9.4605
순현금흐름:
$-11.45M
1주 성능:
+5.81%
1개월 성능:
-37.33%
6개월 성능:
-37.84%
1년 성능:
-82.84%
1일 변동 폭
$4.4501
$4.78
1주일 범위
$4.30
$4.97
52주 변동 폭
$1.50
$44.10
Hcw Biologics Inc Stock (HCWB) Company Profile
명칭
Hcw Biologics Inc
전화
954-842-2024
주소
2929 N COMMERCE PKWY, MIRAMAR
Compare HCWB vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HCWB
Hcw Biologics Inc
|
4.55 | 7.27M | 6.59M | -18.12M | -11.45M | -9.4605 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Hcw Biologics Inc 주식(HCWB)의 최신 뉴스
MSN Money - MSN
HCW Biologics Regains Nasdaq Compliance, Plans Reverse Split - The Globe and Mail
HCW Biologics (HCWB) clears $2.8M disputes and $1.1M lien - Stock Titan
HCW Biologics Inc.: Top Mutual Funds Holders | QNCX | US40423R3030 - marketscreener.com
HCW Biologics Inc.: Fundamental Analysis and Financial Ratings | QNCX | US40423R3030 - marketscreener.com
HCW Biologics Inc.: Dividend historical data and projections - marketscreener.com
HCW Biologics regains Nasdaq compliance, plans stock split - Investing.com UK
HCW Biologics to Implement 1-for-6 Reverse Stock Split - Moomoo
HCW Biologics regains Nasdaq compliance, plans stock split By Investing.com - Investing.com Nigeria
HCW Biologics (NASDAQ: HCWB) regains bid-price compliance and sets 1-for-6 reverse split - Stock Titan
HCW Biologics Regains Nasdaq Bid Price Compliance and Announces 1-for-6 Reverse Stock Split - Quiver Quantitative
HCW Biologics Regained Compliance with Bid Price Rule Per Nasdaq Compliance Letter - GlobeNewswire
HCW BIOL: Target Price Consensus and Analysts Recommendations | HCWB | US40423R2040 - marketscreener.com
HCW Biologics clears Nasdaq bid-price rule, then splits stock 1-for-6 - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
HCW Biologics Inc (HCWB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
HCW Biologics executes 1-for-6 reverse stock split for Nasdaq By Investing.com - Investing.com Australia
HCW Biologics Inc (HCWB) Stock Price, Quote, News & History - Benzinga
HCW Biologics' Reverse Split: A Calculated Gamble to Secure Its Future - BriefGlance
HCW Biologics executes 1-for-6 reverse stock split for Nasdaq - Investing.com
HCW Biologics Announces 1-for-6 Reverse Stock Split to Maintain Nasdaq Listing Compliance Effective June 30, 2026 - Minichart
HCW Biologics Announces 1-for-6 Reverse Stock Split - TipRanks
HCW Biologics (NASDAQ: HCWB) enacts 1-for-6 reverse split to support Nasdaq bid-price compliance - Stock Titan
HCW Biologics Announces 1-for-6 Reverse Stock Split Effective on June 30, 2026 - GlobeNewswire
HCW Biologics Inc (HCWB) Valuation: PE, PB & Fair Value Analysis - TradingKey
HCW Biologics, Inc. Actuals & Estimates (NASDAQ:HCWB) - TradingView
HCW Biologics Inc (HCWB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
[EFFECT] HCW Biologics Inc. SEC Filing - Stock Titan
HCW Biologics Inc (HCWB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
HCW Biologics Inc (HCWB) Institutional Confidence - TradingKey
HCW Biologics (HCWB) files exhibits-only S-1 amendment with new exhibits - Stock Titan
HCW Biologics Inc (HCWB) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
HCW Biologics Inc (HCWB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
HCW Biologics Inc (HCWB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
HCW Biologics Inc (HCWB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
HCW Biologics Inc. (HCWB) Rallies 3.5% as Stock Tests Key Resistance Near $1.24Fund Manager Survey - dars.gov.et
HCW Biologics Shareholders Approve Governance and Capital Measures - The Globe and Mail
HCW Biologics takes back rights to commercial-ready reagents - MSN
HCW Biologics reports positive early alopecia trial data - grafa.com
What's Going On With HCW Biologics Stock Tuesday?HCW Biologics (NASDAQ:HCWB) - Benzinga
HCWB: Preliminary Results from HCW Biologics' Phase 1 Trial Show Promising Data - GuruFocus
HCW Biologics reports positive early data for autoimmune drug By Investing.com - Investing.com Australia
HCW Biologics reports positive early data for autoimmune drug - Investing.com
HCW Biologics Announces Positive Results for Preliminary - GlobeNewswire
HCW Biologics Inc. Files Form 8-K with SEC Detailing Company and Stock Information - Minichart
HCW Biologics (HCWB) AGM 2026 Summary - Quartr
Shareholders back HCW Biologics (NASDAQ: HCWB) 2026 board slate - Stock Titan
HCW Biologics (HCWB) Slides to $1.28 as Selling Pressure PersistsIV Contraction - dars.gov.et
HCW Biologics Q1 2026 Earnings: Unexpected Profit Surge Defies Analyst EstimatesPost-Earnings Reaction - dars.gov.et
Hcw Biologics Inc (HCWB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.64%
자본화:
|
볼륨(24시간):